Personalized Treatment Plans
497 articles
Personalized Treatment Plans in the Fight Against PC
David Dessert explains that his aunt’s genetic testing for BRCA2 mutation directed his own treatment for pancreatic cancer.
Embracing Optimism
Laurie MacCaskill is a long-term survivor of pancreatic cancer. She followed a personalized treatment plan, and focused her energy on remaining optimistic.
Cancer Commons and xCures Hope to Use Real-World Data to Improve Care
Lola Rahib and Patrick van der Valk explain how Cancer Commons and xCures are using real-world data to improve care for future patients.
Thriving After Surviving Pancreatic Cancer
Nancy Nebenzahl, a sever-year survivor of pancreatic cancer, had a Whipple and a personalized treatment plan. She supplemented this with acupuncture and exercise to ease the side effects.
New Trial to Find Biomarkers to Guide Treatment
Drs. Jennifer Knox and Elizabeth Jaffee lead the PASS-01 trial using biomarkers and other measures to choose individualized treatment.
Alternating Protocols to Attack Pancreatic Cancer
Working with his oncologist, Dr. Mark Fishman decided to follow non-standard alternating protocols to treat his pancreatic cancer.
Finding a Treatment Geared to My Cancer
Samuel Chi describes his search for a pancreatic cancer treatment that allows him to live comfortably and reduce his tumor so he can have surgery.
Taking a Different Approach to Pancreatic Cancer Treatment
When Dr. Stephen Bigelsen was diagnosed with stage IV pancreatic cancer, he found a doctor to created a personalized treatment plan.
Patient-Focused Research to Better Understand Pancreatic Cancer
Dr. Diane Simeone stresses the importance of research and clinical trials to get better results for pancreatic cancer patients.
Another Day to Live
Marc Binder is living with stage IV pancreatic cancer, thanks to a personalized treatment plan that allows him to keep active.
A Look Back at Research in 2024
Research in 2024 focused on personally tailored treatments, countering the most difficult effects of pancreatic cancer, and clinical trials.
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
Picking the Right Team
Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.
Working with Oncologists Willing to Take Risks
Anne Glauber chooses the new science of slow dosing of chemotherapy for her pancreatic treatment. She looks to developing science for future treatments.
I Wanted Immunotherapy!
When Daniel Miller was diagnosed with pancreatic cancer he knew he didn’t want chemotherapy—he wanted immunotherapy!